Free Trial

Perpetual Ltd Makes New Investment in Healthcare Realty Trust Incorporated (NYSE:HR)

Healthcare Realty Trust logo with Finance background

Perpetual Ltd acquired a new stake in Healthcare Realty Trust Incorporated (NYSE:HR - Free Report) in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund acquired 26,060 shares of the real estate investment trust's stock, valued at approximately $442,000.

Other large investors also recently added to or reduced their stakes in the company. Dimensional Fund Advisors LP raised its stake in shares of Healthcare Realty Trust by 7.2% during the 2nd quarter. Dimensional Fund Advisors LP now owns 5,856,286 shares of the real estate investment trust's stock worth $96,513,000 after acquiring an additional 395,243 shares in the last quarter. Frank Rimerman Advisors LLC acquired a new position in Healthcare Realty Trust during the 2nd quarter valued at approximately $221,000. EverSource Wealth Advisors LLC increased its stake in Healthcare Realty Trust by 260.6% during the 2nd quarter. EverSource Wealth Advisors LLC now owns 2,809 shares of the real estate investment trust's stock valued at $50,000 after purchasing an additional 2,030 shares in the last quarter. Evergreen Capital Management LLC acquired a new position in Healthcare Realty Trust during the 2nd quarter valued at approximately $291,000. Finally, Point72 DIFC Ltd acquired a new stake in shares of Healthcare Realty Trust in the second quarter worth $828,000.

Insider Transactions at Healthcare Realty Trust

In other news, COO Robert E. Hull sold 10,000 shares of Healthcare Realty Trust stock in a transaction that occurred on Tuesday, December 17th. The shares were sold at an average price of $17.48, for a total transaction of $174,800.00. Following the sale, the chief operating officer now owns 171,400 shares in the company, valued at $2,996,072. This trade represents a 5.51 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, Director Thomas N. Bohjalian acquired 7,750 shares of the company's stock in a transaction dated Friday, November 22nd. The shares were purchased at an average price of $17.39 per share, for a total transaction of $134,772.50. Following the purchase, the director now directly owns 50,002 shares of the company's stock, valued at approximately $869,534.78. This trade represents a 18.34 % increase in their ownership of the stock. The disclosure for this purchase can be found here. Insiders have purchased a total of 18,750 shares of company stock worth $323,723 in the last three months. Company insiders own 0.56% of the company's stock.

Analyst Ratings Changes

A number of analysts recently issued reports on HR shares. Wedbush downgraded shares of Healthcare Realty Trust from a "neutral" rating to an "underperform" rating and lowered their price target for the stock from $18.00 to $16.00 in a report on Thursday, January 2nd. Wells Fargo & Company reaffirmed an "underweight" rating and set a $17.00 price objective (up from $16.00) on shares of Healthcare Realty Trust in a report on Tuesday, October 1st. Jefferies Financial Group cut shares of Healthcare Realty Trust from a "buy" rating to a "hold" rating and cut their price objective for the stock from $19.00 to $17.00 in a research report on Thursday, January 2nd. Finally, JPMorgan Chase & Co. cut shares of Healthcare Realty Trust from an "overweight" rating to a "neutral" rating and set a $19.00 price target for the company. in a research report on Friday, December 20th. Two analysts have rated the stock with a sell rating and five have issued a hold rating to the company's stock. According to data from MarketBeat.com, the company presently has an average rating of "Hold" and an average price target of $17.14.

View Our Latest Report on HR

Healthcare Realty Trust Stock Up 0.8 %

Shares of Healthcare Realty Trust stock traded up $0.13 on Thursday, hitting $16.60. The company's stock had a trading volume of 1,460,779 shares, compared to its average volume of 2,424,945. Healthcare Realty Trust Incorporated has a 52-week low of $12.77 and a 52-week high of $18.90. The firm has a fifty day moving average price of $17.20 and a 200-day moving average price of $17.55. The company has a market capitalization of $5.88 billion, a P/E ratio of -10.50 and a beta of 0.94.

Healthcare Realty Trust Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Wednesday, November 27th. Shareholders of record on Tuesday, November 12th were issued a $0.31 dividend. The ex-dividend date of this dividend was Tuesday, November 12th. This represents a $1.24 dividend on an annualized basis and a yield of 7.47%. Healthcare Realty Trust's dividend payout ratio (DPR) is -78.48%.

Healthcare Realty Trust Profile

(Free Report)

Healthcare Realty NYSE: HR is a real estate investment trust (REIT) that owns and operates medical outpatient buildings primarily located around market-leading hospital campuses. The Company selectively grows its portfolio through property acquisition and development. As the first and largest REIT to specialize in medical outpatient buildings, Healthcare Realty's portfolio includes more than 700 properties totaling over 40 million square feet concentrated in 15 growth markets.

Further Reading

Institutional Ownership by Quarter for Healthcare Realty Trust (NYSE:HR)

Should You Invest $1,000 in Healthcare Realty Trust Right Now?

Before you consider Healthcare Realty Trust, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Healthcare Realty Trust wasn't on the list.

While Healthcare Realty Trust currently has a "Reduce" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

20 Stocks to Sell Now Cover

MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio?

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Palantir’s Explosive Growth: Buy Now or Wait for a Dip?
5 Stocks to BUY NOW in February 2025
How To Invest in Crypto as A Complete BEGINNER in 2025

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines